{
    "id": 25315,
    "fullName": "PDCD4 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "PDCD4 dec exp indicates decreased expression of the Pdcd4 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 27250,
        "geneSymbol": "PDCD4",
        "terms": [
            "PDCD4",
            "H731"
        ]
    },
    "variant": "dec exp",
    "createDate": "09/07/2016",
    "updateDate": "12/10/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8224,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, low expression of Pdcd4 was associated with resistance to Linsitinib (OSI-906) in colorectal cancer cell lines in culture and in xenograft models (PMID: 25573956).",
            "molecularProfile": {
                "id": 26201,
                "profileName": "PDCD4 dec exp"
            },
            "therapy": {
                "id": 798,
                "therapyName": "Linsitinib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6578,
                    "pubMedId": 25573956,
                    "title": "Inhibition of p70S6K1 Activation by Pdcd4 Overcomes the Resistance to an IGF-1R/IR Inhibitor in Colon Carcinoma Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25573956"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8225,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Linsitinib (OSI-906) and PF-4708671 inhibited growth of Linsitinib (OSI-906)-resistant colorectal cancer cell lines with low expression of Pdcd4 in culture and decreased tumor growth in cell line xenograft models (PMID: 25573956).",
            "molecularProfile": {
                "id": 26201,
                "profileName": "PDCD4 dec exp"
            },
            "therapy": {
                "id": 4666,
                "therapyName": "Linsitinib + PF-4708671",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6578,
                    "pubMedId": 25573956,
                    "title": "Inhibition of p70S6K1 Activation by Pdcd4 Overcomes the Resistance to an IGF-1R/IR Inhibitor in Colon Carcinoma Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25573956"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26201,
            "profileName": "PDCD4 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}